Figure 1
![Main bioactive components of N. sativa: (A) carvacrol (5-isopropyl-2-methylphenol; National Center for Biotechnology Information. PubChem Database compound identification number [CID] 10364), (B) 4-cymene (4-isopropyltoluene; CID 7463), (C) thymoquinone (4-cymene-2,5-dione; CID 10281), (D) nigellidine (CID 136828302), (E) nigellicine (CID 11402337), and (F) α-hederin (CID 73296).](https://sciendo-parsed.s3.eu-central-1.amazonaws.com/647067f983f1392090d68d7d/j_abm-2020-0020_fig_001.jpg?X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Credential=ASIA6AP2G7AKFF3SZNPI%2F20260128%2Feu-central-1%2Fs3%2Faws4_request&X-Amz-Date=20260128T005041Z&X-Amz-Expires=3600&X-Amz-Security-Token=IQoJb3JpZ2luX2VjEJT%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEaDGV1LWNlbnRyYWwtMSJHMEUCIH%2Fn4E%2FNMtvTQ%2BU10I4oqjvUieDitY%2F%2BJiY%2FJwj%2Fc%2BK9AiEA575q1qRjXUo%2BdQJOtR%2FTYQIcchYBFXFs%2F4OM%2Fz84T%2F4qvAUIXRACGgw5NjMxMzQyODk5NDAiDEt3%2BU5BLggODLjgiyqZBTA9qcDK7QMHEiP1M7H5VKH4Mkwn9UZB3sFVw0BhJh%2BlAx8eGfaBnaY6hzNn12SIEpiU95m7Pa1nnUsNENIKqe9ORlSqHwXHoO2JqbeBFMrqbgPhLzm2s1It7QbOj%2BDwCCkdQAu0kCj%2BvnmunG9kwFBoTUlCLjN8hEu%2F%2FzmqUdxvh5pDzIfVpHHg%2Bq1jDwUQZ%2BjKY4wWLaFkPCQuDK6RwF66Vj%2BdtmOWigerD10ZW4sLYTOay0PJhKtbgkUczcHERrr3fe%2Fpy9lMe7bcLERw8KBdcz18Y6kETPaHfEzsg7iDYIntrAiGz1VmyOp7GOvP1yVjC5XLZ683ra4EvxFOP6apx%2BcBkqFCQQmJyHXq9XgRYaQi8HKn41avnliDVT%2FYQxzU1bOogkoYK6XxZbVeapT8o8pupeo8W%2BMocRXF7uhhwCtId%2FIkOqbK3yNN6ziZ3MtEmRYXFTZ65EUHblAyhsoJlDsO588gN57p0UQ0YjV7eWSKsi9dJxMNVnjHBOzZIkVwalb5hhnC9ZAGIcsfQldcVo907zOLwY%2BhQVT8tchDS1LiPcTiyBCAfccmiR0XdU8G%2F4xcYJKb6H2hfLHrBpfDAHfUmQAAJnmVk5ui5Wp%2BOaymShR6dMuVl9k5LWUmOtsaTb5u%2BQ8W4%2BR2L5aexwXaPq6g%2FyI2YbrzlG1Uv8ZaIo55oF5drnL%2BZ%2FRnQMuTyTrvMRO7gZyE61Y47CF3ULikSKS2jls10819AJJBFFSq0hIytYPTtc7dxZN457XjFALcdSG1zrFthFm8JB21aNk5jnWyxVgDitEHWRl8dE55n133aGC2G9fxTt3NngR4i%2Fwpw3kH9%2BDIvg3Q1F3GPPYGUuijwPFgam5%2FKgbvsFWf%2Fk%2BVmD1%2Bn%2F37ML6n5MsGOrEBCo%2FKH4UL6T9mS5l5GKuNF7Bwl%2F%2F7BuwjdnU%2B%2Fm%2BsTTiiGcgH4gsf2CcYdALvONpp5Z86Gth20IZDlqgr6renhEwJqlVDE%2FSs6GujxaKVRZ9gg%2FOxA%2Bkbt0B5xpI1jv7TT1v9h2Qn%2FPwectI3rjoGqv3R%2FZuDCzfSGh5i%2FSzSGiTRd99wglVB4k4%2B2CgYstcf1yuKDRFqDWSU0eADWpO%2B17NaSWU79JNMwvYtG%2FpKa00x&X-Amz-Signature=25f40e6bdaed823f00e54ba50be45116a818ea00278eeef7818394f8ee0280bd&X-Amz-SignedHeaders=host&x-amz-checksum-mode=ENABLED&x-id=GetObject)
Figure 2

Subacute toxicity of Nigella sativa in animal studies
| Substance/dose | Animals used | Exposure period | Observation period | Main results | Reference |
|---|---|---|---|---|---|
| N. sativa seeds AE 10 mL/kg, p.o. | Male Sprague Dawley rats | 14 days | 30 days | ↑ Serum γ-GT and ALT levels. Unchanged serum ALP levels and histopathological examinations | [63] |
| N. sativa seed oil 10 mL/kg, p.o. | Rats | 48 h | Not specified | No toxicity | [53] |
| Mice | |||||
| N. sativa seeds AE, ME, and CE 6 g/kg, p.o | Both sexes of young virgin mice | 14 days | Same 14 days | No toxicity wide margin of safety | [4] |
| N. sativa powder 90, 180, 360, and 540 mg/kg, locally | Normal adult male albino rats | 1, 2, and 4 weeks | Same 4 weeks | Transient alterations in both anticoagulant and coagulant functions | [54] |
| N. sativa powder 0.01, 0.1, and 1 g/kg/day, p.o | Male Sprague Dawley rats | 28 days | Same 28 days | No toxicity | [64] |
| N. sativa AE 2, 6.4, 21, 33, and 60 g/kg, orally), p.o | Mus musculus | 6 weeks | Same 6 weeks | 21 g/kg: hepatotoxic 60 g/kg: high mortality | [65] |
| mice | |||||
| BSH 100, 500, 1,000, and 2,000 mg/kg, p.o | Male Sprague Dawley rats | 14 days | 28 days | No toxicity | [66] |
Cytotoxic and genotoxic properties of Nigella sativa in vitro
| Substance | Concentration period | Period | Cell type | Main results | Reference |
|---|---|---|---|---|---|
| N. sativa oil | 0.25, 0.5, and 1 μg/mL | 95 h | Gingival fibroblasts | No cytotoxicity | [67] |
| N. sativa EE | 0–2 mg/mL | 24 h | Rat L6 muscle cell line | EC50 >2,000 μg/mL against L6myc cell lines | [68] |
| N. sativa EE | 100, 500, and 1,000 μg/mL | 48 h | Isolated rat splenocytes | Cytotoxic effects at 500 and 1,000 μg/mL | [57] |
| N. sativa EO and ME, PE, CE, AE, and ether extract | 10, 100, and 1,000 μg/mL | 24 h | BSL | Higher toxicity by chloroform and petroleum ether extracts. | [69] |
| N. sativa seed VO | 500, 250, 125, and 62.5 μg/mL | Not specified | SCL, SCL-6, SCL-37′6, NUGC-4, Kato-3, 3T6 | LC50 SCL 155.02 μg/mL | [70] |
| N. sativa PE and AE | 670 μg/mL | 24 h | HL60 | IC50 PE 654 μg/mL | [71] |
| N. sativa EO | 100 mg/mL | 24 h | Huh7 human cells | No cytotoxicity | [72] |
| N. sativa seed oil | 50–500 μg/mL | U-1242, U251, U-87, U-373, A172 and SNB19 | IC50 260 μg/mL | [58] | |
| AE of N. sativa | 0.5, 1, 4, 8, 9, and 18 mg/mL | Human C3A cells | Positive micronucleus test extract from Setta | [73] | |
| N. sativa seed ME, NE, and CE | 2, 2.25, 2.5, 2.75, and 3 μg/mL of methanolic, n-hexane. | 24 h | HeLa cells | IC50 methanolic: 2.28 μg/mL | [74] |
| N. sativa AE | 79.5 μg/mL | 48 h | F 344 hepatocytes treated with MNNG | ↑ Chromosomal aberrations | [59] |
Acute toxicity of Nigella sativa in animal studies
| Substance/dose | Animals used | Observation period | LD50 | Reference |
|---|---|---|---|---|
| N. sativa seed VO, FO, and AE, i.p. | SWR mice | 24 h | AE: 3,020 mg/kg | [51] |
| N. sativa seed FO 0.25, 0.5, 1, 2, 3, 4, and 6 mL/kg, i.p. | Both sexes of mice | 15 days | 2.06 mL/kg | [49] |
| N. sativa seed FO 10, 15, 20, 25, 30, 40, and 50 mL/kg, p.o | 28.8 mL/kg | |||
| N. sativa seeds AE, ME and CE 6, 9, 14 and 21 g/kg, p.o. | Both sexes of young virgin mice | 7 days | No mortality | [4] |
| N. sativa EO 0.2, 0.4, 0.4, 0.8, 1 mg/kg, p.o. | Both sexes of white Wistar rats and NMRI | Not specified | No mortality | [62] |
Subchronic toxicity of Nigella sativa in animal studies
| Substance/dose | Animals used | Exposure period | Observation period | Main results | Reference |
|---|---|---|---|---|---|
| N. sativa seeds 20 and 100 g/kg, p.o. | 7-day-old Hibro broiler chicks | 7 weeks | Same 7 weeks | No toxicity | [55] |
Chronic toxicity of Nigella sativa in animal studies
| Substance/dose | Animals used | Exposure period | Observation period | Main results | Reference |
|---|---|---|---|---|---|
| N. sativa FO 2 mL/kg, p.o. | Wistar-Kyoto rats | 12 weeks | Same 12 weeks | ↓ Leukocyte and Plt | [49] |
| N. sativa FO 1 mL/kg, p.o. | Wistar-Kyoto rats | 12 weeks | Same 12 weeks | ↓ Leukocyte and Plt | [56] |
Nigella sativa toxicity in humans
| Substance | Concentration | Exposure route/period | Case history | Main results | Reference |
|---|---|---|---|---|---|
| Pure oil of black cumin | Not specified | Used on the neck for 3 months | 28-year-old man for treatment of sore throat | Allergic contact dermatitis | [60] |
| EO of the seeds of black cumin | Not specified | Repeatedly applied as an ointment | 31-year-old woman with an 8-month history of eczema on both hands | Allergic contact dermatitis | [61] |
| Capsules of BCEO | Containing 500 mg of organic N. sativa oil and 7.5 mg of vitamin E | Daily 15 days | 56-year-old woman | Severe bullous target-like lesions, compatible with erythema multiforme | [80] |